Anuh Pharma Limited (BOM:506260)
India · Delayed Price · Currency is INR 81.44
+3.67 (4.72%)
At close: Jun 16, 2026
Anuh Pharma Ratios and Metrics
Market cap in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 15, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
| 8,162 | 6,727 | 7,459 | 12,308 | 3,990 | 4,307 | |
Market Cap Growth | -22.81% | -9.81% | -39.39% | 208.46% | -7.36% | -4.82% |
Enterprise Value | 7,631 | 6,598 | 7,081 | 11,824 | 3,486 | 4,209 |
Last Close Price | 81.44 | 67.12 | 73.17 | 119.27 | 38.08 | 40.42 |
PE Ratio | 19.86 | 16.39 | 15.75 | 20.49 | 11.03 | 14.09 |
PS Ratio | 1.06 | 0.87 | 1.13 | 1.90 | 0.76 | 0.89 |
PB Ratio | 2.32 | 1.91 | 2.29 | 4.23 | 1.65 | 2.02 |
P/TBV Ratio | 2.32 | 1.91 | 2.29 | 4.23 | 1.66 | 2.02 |
P/FCF Ratio | - | - | 43.93 | 155.62 | 7.62 | 15.81 |
P/OCF Ratio | - | - | 20.09 | 95.22 | 7.40 | 14.92 |
EV/Sales Ratio | 0.99 | 0.86 | 1.07 | 1.83 | 0.66 | 0.87 |
EV/EBITDA Ratio | 12.36 | 10.69 | 11.21 | 15.78 | 6.56 | 8.74 |
EV/EBIT Ratio | 15.16 | 13.11 | 12.89 | 17.68 | 7.97 | 11.52 |
EV/FCF Ratio | - | - | 41.71 | 149.51 | 6.66 | 15.45 |
Debt / Equity Ratio | 0 | 0 | 0.03 | 0.01 | 0.00 | 0.02 |
Debt / EBITDA Ratio | 0.00 | 0.00 | 0.17 | 0.04 | 0.02 | 0.09 |
Debt / FCF Ratio | - | - | 0.64 | 0.34 | 0.02 | 0.16 |
Net Debt / Equity Ratio | -0.15 | -0.15 | -0.19 | -0.20 | -0.22 | -0.10 |
Net Debt / EBITDA Ratio | -0.86 | -0.86 | -0.99 | -0.79 | -0.98 | -0.44 |
Net Debt / FCF Ratio | 4.88 | 4.88 | -3.68 | -7.53 | -1.00 | -0.77 |
Asset Turnover | 1.45 | 1.45 | 1.39 | 1.52 | 1.40 | 1.43 |
Inventory Turnover | 5.40 | 5.40 | 6.76 | 6.64 | 5.34 | 4.72 |
Quick Ratio | 1.44 | 1.44 | 1.68 | 1.69 | 1.42 | 1.23 |
Current Ratio | 2.22 | 2.22 | 2.11 | 2.22 | 1.91 | 1.98 |
Return on Equity (ROE) | 12.10% | 12.10% | 15.34% | 22.56% | 15.90% | 15.11% |
Return on Assets (ROA) | 5.91% | 5.91% | 7.21% | 9.83% | 7.27% | 6.72% |
Return on Invested Capital (ROIC) | 12.43% | 13.55% | 17.23% | 24.38% | 17.46% | 14.87% |
Return on Capital Employed (ROCE) | 14.20% | 14.20% | 16.70% | 22.80% | 17.90% | 16.90% |
Earnings Yield | 5.03% | 6.10% | 6.35% | 4.88% | 9.07% | 7.10% |
FCF Yield | -1.33% | -1.62% | 2.28% | 0.64% | 13.12% | 6.33% |
Dividend Yield | 1.93% | 2.23% | 2.05% | 1.05% | 2.63% | 2.17% |
Payout Ratio | 36.47% | 36.47% | 26.45% | 16.69% | 24.18% | 24.73% |
Buyback Yield / Dilution | 0.11% | 0.11% | - | - | - | - |
Total Shareholder Return | 2.01% | 2.35% | 2.05% | 1.05% | 2.63% | 2.17% |